E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 065.5 INR 0.94%
Market Cap: 201.9B INR

Intrinsic Value

The intrinsic value of one EMCURE stock under the Base Case scenario is 857.27 INR. Compared to the current market price of 1 065.5 INR, Emcure Pharmaceuticals Ltd is Overvalued by 20%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EMCURE Intrinsic Value
857.27 INR
Overvaluation 20%
Intrinsic Value
Price
E
Worst Case
Base Case
Best Case

Valuation History
Emcure Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
EMCURE
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for EMCURE cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Emcure Pharmaceuticals Ltd
NSE:EMCURE
IN
Pharmaceuticals
Market Cap
201.5B INR
IPO
Jul 10, 2024
IN
Pharmaceuticals
Market Cap
201.5B INR
IPO
Jul 10, 2024
Price
₹false
EPS
₹false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Emcure Pharmaceuticals Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Emcure Pharmaceuticals Ltd

Balance Sheet Decomposition
Emcure Pharmaceuticals Ltd

Current Assets 44.6B
Cash & Short-Term Investments 3.3B
Receivables 20.3B
Other Current Assets 20.9B
Non-Current Assets 36.7B
Long-Term Investments 650.8m
PP&E 23.8B
Intangibles 10B
Other Non-Current Assets 2.2B
Efficiency

Free Cash Flow Analysis
Emcure Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Emcure Pharmaceuticals Ltd

Revenue
124.4B INR
Cost of Revenue
-48.5B INR
Gross Profit
75.9B INR
Operating Expenses
-58.9B INR
Operating Income
17B INR
Other Expenses
-7.1B INR
Net Income
9.9B INR
Fundamental Scores

EMCURE Profitability Score
Profitability Due Diligence

Emcure Pharmaceuticals Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROE
Positive 3-Year Average ROIC
Exceptional ROE
62/100
Profitability
Score

Emcure Pharmaceuticals Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

EMCURE Solvency Score
Solvency Due Diligence

Emcure Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
67/100
Solvency
Score

Emcure Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EMCURE Price Targets Summary
Emcure Pharmaceuticals Ltd

Wall Street analysts forecast EMCURE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EMCURE is 1 565.7 INR with a low forecast of 1 454.4 INR and a high forecast of 1 732.5 INR.

Lowest
Price Target
1 454.4 INR
36% Upside
Average
Price Target
1 565.7 INR
47% Upside
Highest
Price Target
1 732.5 INR
63% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Emcure Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for EMCURE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one EMCURE stock?

The intrinsic value of one EMCURE stock under the Base Case scenario is 857.27 INR.

Is EMCURE stock undervalued or overvalued?

Compared to the current market price of 1 065.5 INR, Emcure Pharmaceuticals Ltd is Overvalued by 20%.

Back to Top